229 related articles for article (PubMed ID: 27607334)
1. MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis.
Cordes F; Brückner M; Lenz P; Veltman K; Glauben R; Siegmund B; Hengst K; Schmidt MA; Cichon C; Bettenworth D
Inflamm Bowel Dis; 2016 Oct; 22(10):2341-55. PubMed ID: 27607334
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R
J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.
Assa A; Vong L; Pinnell LJ; Rautava J; Avitzur N; Johnson-Henry KC; Sherman PM
Inflamm Bowel Dis; 2015 Feb; 21(2):297-306. PubMed ID: 25590952
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
9. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis.
Breugelmans T; Van Spaendonk H; De Man JG; De Schepper HU; Jauregui-Amezaga A; Macken E; Lindén SK; Pintelon I; Timmermans JP; De Winter BY; Smet A
J Crohns Colitis; 2020 Jul; 14(7):974-994. PubMed ID: 32003421
[TBL] [Abstract][Full Text] [Related]
10. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.
Huang Z; Shi T; Zhou Q; Shi S; Zhao R; Shi H; Dong L; Zhang C; Zeng K; Chen J; Zhang J
Gut; 2014 Aug; 63(8):1247-57. PubMed ID: 24000293
[TBL] [Abstract][Full Text] [Related]
11. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental Colitis.
Fröhling M; Tepasse P; Intemann J; Sambale M; Sherwood J; Paruzel P; Tiemeyer NM; Nowacki TM; Brückner M; Mennigen R; Lügering A; Echtermeyer F; Pap T; Stratis A; Bettenworth D
Inflamm Bowel Dis; 2018 Nov; 24(12):2579-2589. PubMed ID: 30053064
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus carrying thymosin β
Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
[TBL] [Abstract][Full Text] [Related]
14. IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair.
Lopetuso LR; De Salvo C; Pastorelli L; Rana N; Senkfor HN; Petito V; Di Martino L; Scaldaferri F; Gasbarrini A; Cominelli F; Abbott DW; Goodman WA; Pizarro TT
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9362-E9370. PubMed ID: 30224451
[TBL] [Abstract][Full Text] [Related]
15. Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis.
Nighot P; Young K; Nighot M; Rawat M; Sung EJ; Maharshak N; Plevy SE; Ma T; Blikslager A
Inflamm Bowel Dis; 2013 Dec; 19(13):2867-77. PubMed ID: 24030525
[TBL] [Abstract][Full Text] [Related]
16. IL-10/microRNA-155/SHIP-1 signaling pathway is crucial for commensal bacteria induced spontaneous colitis.
Li Y; Tian Y; Zhu W; Gong J; Guo Z; Guo F; Gu L; Li J
Biochem Pharmacol; 2016 Sep; 116():100-6. PubMed ID: 27395764
[TBL] [Abstract][Full Text] [Related]
17. SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway.
Wei SC; Yang-Yen HF; Tsao PN; Weng MT; Tung CC; Yu LCH; Lai LC; Hsiao JH; Chuang EY; Shun CT; Ni YH; Xavier RJ; Podolsky DK; Yen JJY; Wong JM
Inflamm Bowel Dis; 2017 Oct; 23(10):1730-1740. PubMed ID: 28906292
[TBL] [Abstract][Full Text] [Related]
18. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
19. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of microRNA-10b promotes DSS-induced inflammatory response via impairing intestinal barrier function.
Zhao K; Wang C; Liu Y; Li Y; Hui T; Wang G; Zhang X; Xue X; Kang J; Feng G
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 2):48-54. PubMed ID: 36343490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
